Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Giulio Tarro

Giulio Tarro

President Foundation de Beaumont Bonelli for Cancer Research Italy

Gilbert Glady

Gilbert Glady

European Bio Immun(G)en Medicine Association France

Charles J Malemud

Charles J Malemud

Case Western Reserve University School Medicine USA

Rongtuan Lin

Rongtuan Lin

McGill University Canada

Madeleine Duvic

Madeleine Duvic

Anderson Cancer Center USA

Robert H Schiestl

Robert H Schiestl

University of California USA

Kathleen B Schwarz

Kathleen B Schwarz

Johns Hopkins University School of Medicine USA

Walter Schubert

Walter Schubert

ToposNomos Ltd. Germany

Immunology 2020

About Conference


Conference Series invites all the participants across the world to attend International Conference on Immunology to be held during November 02-03, 2020 in Rome, Italy which includes prompt keynote presentations, Oral talks, e-Poster presentations, Young Research Forum(YRF) and Exhibitions.

Why to attend?

With members from around the world focused on learning about Immunology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Immunology community. World-renowned speakers, the most recent techniques, developments, and the newest updates in Immunology are hallmarks of this conference.

  • Opportunity to attend the presentations delivered by Eminent Scientists from all over the world
  • Accepted abstracts will be published in Journal of Immunology and provided with DOI
  • Discuss your ideas and views with pioneers in the fields of Immunology
  • Be a part of the interactive debates, plenary sessions and discussions about the current issues in the area of Immunology and come to a consensus using evidence-based expert opinion

Target Audience:

  • Immunologists
  • Rheumatologists
  • Microbiologists
  • Pulmonologists
  • Allergists
  • Pathologists
  • Clinical Immunologists
  • Physicians
  • Pediatricians
  • Virologists
  • Biotechnologists
  • Immunology professionals
  • Infectious diseases treatment doctors
  • University Professors
  • Various Societies and their members
  • Institutes-Medical Schools Students
  • Research Scholars
  • Laboratory technicians
  • Business Entrepreneurs
  • Manufacturing Medical Devices Companies

 

 

Sessions

Session 01: Immune System and Immunology

The immune system is a host protection system that includes several biological structures and processes in a disease-protecting organism. Immunology is a diverse and growing discipline that can be defined as the study of the mechanisms of host defences involving tissues, cells and molecules. Immunologists try to understand the nature of the immune system, how the body protects itself against infection and what happens when everything goes wrong.

The current world of immunological research has expanded considerably, even in the current environment of highly interdisciplinary and collaborative science, future immunologists will probably need to be at least familiar with computational, structural and system biology, nanotechnology and tissue engineering for example. At the same time, from primarily a host defence mechanism to a fundamental homeostatic system with organism-wide physiological and clinical significance and potentially transformative biotechnological and therapeutic applications, our perspective of the immune system has gradually developed.

The current world of immunological research has expanded considerably, even in the current environment of highly interdisciplinary and collaborative science, future immunologists will probably need to be at least familiar with computational, structural and system biology, nanotechnology and tissue engineering for example. At the same time, from primarily a host defence mechanism to a fundamental homeostatic system with organism-wide physiological and clinical significance and potentially transformative biotechnological and therapeutic applications, our perspective of the immune system has gradually developed.

Session 02:  OncoImmunology

Oncoimmunology or Cancer Immunology is one of immunotherapy's most popular applications. The tumor microenvironment is a major aspect of cancer biology, leading to tumor initiation, tumor growth and therapy responses. The primary focus of Cancer Immunology Researches is to learn how the immune system works or does not work against cancer. The success of cancer immunotherapy in recent years, including monoclonal antibodies (mAbs), cancer vaccinations, adoptive cancer therapy and immune regulation point therapy, has revolutionized conventional cancer treatment. New plan of actions for blocking immune control point regulators, overcoming immune resistance such as engineered T-cell therapy or identifying novel tumor antigens through next-generation sequencing have now opened a new age of immunotherapy for cancer.

Session 03: Autoimmune Diseases and HIV

Autoimmune diseases arise when inherited autoimmunity progress to pathogenic autoimmunity. Genetic factors as well as environmental causes dictate this development. The global market size of Autoimmune Disease Therapeutics was $109,833 million in 2017 and is expected to reach $153,320 million by the end of 2025, with a CAGR of 4.2% 2018-2025.

HIV is a category of diseases caused by human immunodeficiency virus infection. HIV weakens the immune system and impedes the ability of the body to combat disease as they destroy T cells, macrophages and dendritic cells. There is no treatment for HIV at the moment, but there are many clinical studies devoted to a cure. Developing an HIV vaccine would save millions of lives. Share your research findings on Autoimmunity and HIV to the world; this can be possible by our Immunology Congress.

Session 04: Transplantation and Computational Immunology

Transplantation, the process of moving cells, tissues and organs from one location to another to replace or repair damaged or ill organs and tissues. During transplantation, the immune system plays an important role. In transplant medicine, immunological research has led to enormous advances. Nevertheless, the most formidable obstacle to successful transplantation remains immune rejection. Continued research is needed to find ways to mitigate the risk of rejection, enhance diagnosis and sustain the transplant's long-term survival, all of which would have a significant impact on the supply of strained tissue.

Computational immunology is a research discipline that combines approaches to immunology from high-throughput genomics and bioinformatics. This usually aims to turn immunological information into computational problems, solving them by using mathematical and statistical methods and then translating the findings into definitions of immunological significance. The Immunology Conference is an excellent platform to discuss with co-researchers and students in order to know more interesting developments in this field.

Session 05:  Immunogenetics

Immunogenetics is the medical genetics science which explores the interaction between the immune system and genetics. This involves researching normal immunological processes and discovering genetic variations that lead to immune deficiencies, which can lead to the discovery of new immune disease therapeutic targets.

Immunogeneticist’s main focus is on recognizing, characterizing and sequencing genes coding for multiple receptors and immune response mediators. Scientists have been able to perform blood transfusions and organ transplants safely by researching Immunogenetics as well as treating autoimmune diseases such as diabetes. In future, Immunogenetics will have a wide platform for young pioneers in research and the development of technologies will facilitate gene-related corrections.

Session 06: Stem Cells Immunology

In addition to being commonly used for regenerative medicine, stem cells are also considered a useful tool in cancer treatment. Stem cells have long been used to renew the immune system for patients treated with radiation or chemotherapy. Stem cells have recently been designed to bring therapeutic reagents to target tumor sites. Cancer vaccines are researched and tested for cancer treatment based on knowledge of cancer stem cells. Using in-duced pluripotent stem cells, active T cells were created to support immunotherapy for cancer. These are due to stem cell's unique characteristics, such as immunological tolerance, migration and tissue repair. Stem cells are used as carriers for carrying drugs or therapeutic vector viruses to tumors in gene therapy for cancer treatment.

Current research reveals a wide range of ways in which stem cells are designed to fight diseases such as cancer. A breakthrough in this field was created by the recent discovery of reprogramming patient-derived cells. There is no doubt that in the future of cancer treatment, stem cell technology will play a major role.

Session 07: NeuroImmunology

The study of the relationship between the central nervous system (brain and spinal cord) and the immune system is Neuroimmunology. Neuroimmunology helps develop new pharmacological treatments for various neurological conditions. Neuroinflammation and neuroimmune activation have been shown to play a role in the ethology of a number of neurological disorders such as stroke, disease of Parkinson and Alzheimer, multiple sclerosis, pain and depression associated with HIV, etc.

Cognitive neuroscience becomes a very powerful way for understanding human cognition, while results can explain functional brain structure, such as operations undertaken by a certain brain area and the network of decentralized, distinct neutral area that support a particular psychological representation. Here is a scientific meeting your new challenges at Immunology Symposium.

Session 08: HaematopoieticLymphoid Malignancies and Immune System Development

Tumors that affect the blood, bone marrow, lungs and lymph system are haematopoietic or lymphoid malignancies. Hematopoietic and lymphoid tissue malignancies include leukaemias, myeloproliferative neoplasms; dyscrasia of plasma cells and neoplasms of dendritic cells. The immune system takes on a double job malignant growth: it counteracts the outgrowth of tumor cells and also shapes the tumor cells immunogenicity. Cells of the disease can defeat the immune system by preventing the activation of T lymphocytes.

In order to focus on these T lymphocyte induction modulators, new immunotherapies have been created. The immune checkpoints, defined as immune system atoms that either turn a flag up or turn a flag down. Through representing T cell function, the vast majority of malignancies protect themselves from the immune system. According to the current research report, an expansion in the interest of profitable is the most essential driver of the market

Session 09: Thyroid Autoimmunity

Hashimoto's thyroiditis, also called Hashimoto's syndrome, is an autoimmune disease, a disorder in which the immune system switches against the body's own tissues. For people with Hashimoto, the thyroid is damaged by the immune system. AITD can be considered the most common endocrine autoimmune disease. The clinical entities found in AITDs are diverse and vary depending on whether there is predominance in the patient of a state of hypothyroidism (HT), hyperthyroidism (GD) or both painless thyroiditis (PT), postpartum thyroiditis (PPT) and sub-acute thyroiditis (SAT). There is a need for an international consensus to diagnose AITD accurately.

Among these patients, regular CVD screening should be considered. These findings may help further the study of AD's common mechanisms, improve patient satisfaction and identify public health policies, especially for patients with RA. The current trend and future aspects can be learned and shared by our Immunology Workshop.

Session 10: Allergy and Immunology

Allergies, also known as allergic diseases, are a number of conditions attributable to the hypersensitivity of the immune system triggered by typically harmless factors in the environment. The division has active research programs based on laboratory, clinical research and publishes more than 50 scientific papers per year. The research programs concentrate on inner-city asthma, the role of allergy sensitivity to the environment in allergic disease, the natural history of food allergy, food allergy treatment, and immune dysfunction pathogenesis in ataxia telangiectasia. In this decade, there is a real cure on the horizon.

Session 11: Immunization and Vaccination

Public health’s goal is to prevent illness. Preventing an infection is much easier and much more cost-effective than treating it. Immunization is a means of providing effective defence against many dangerous and harmful pathogens by stimulating the immune system of an organism.

The development of vaccines against more complex infections such as tuberculosis, malaria and aids has been challenging and has been modest to date. The final success of these infections that involve multiple vaccines, each of which activates a different arm of the immune system. In the longer term, many non-infectious diseases are likely to be used to stop or modulate the course. Therapeutic cancer vaccines have already made progress and potential future targets include obesity, diabetes, asthma and Alzheimer's disease.

Session 12: Immunoresearch and Immunotechnology

Immunotechnology is a technique that incorporates the immune system's cells and molecules. Advances in immunodiagnostic technologies provide the foundation for the design of antigen detection platforms capable of meeting strict tolerance, specificity, rate of assay, robustness and simplicity requirements. Emerging technologies broaden our understanding of the human immune system, but capitalizing on its development would probably require theoretical and functional changes in the way research is conducted.

 

Market Analysis

A glance at Market Analysis of Immunology 

Molecular Immunology 2019 takes a look at the worldwide market visit which centers around Immunology and Immunogenetics its classes and the yearly market esteems for the meds to basic immunological infections and the deadliest auto resistant maladies.

The recent market value on immunology investigate that has been given by the research analyst in the US finishes up saying the worldwide Immunology and molecular medication showcase in the UK is $4.8 billion whereas it is in $11 billion in the USA. It is normal that the market value along the immunology and molecular research will give a climb over the world with $24 billion of every 2018.

 

An ongoing report from the Global Business Intelligence (GBI) states that the worldwide immunology treatment advertise break down is set to grow from the $61.5 billion of every 2015 to an expected $74.2 billion out of 2022, in spite of numerous approaching expiries of the attacked host of immunology treatment. It likewise recommends that there various inevitable items anticipated that would accomplish solid yearly wage incomes amid the conjecture years, despite the fact that they are not imagined to achieve more wage contrasted with those that are created by the current most grounded offering immunology items.

According to the Centers for Disease Control and Prevention (CDC), it is evaluated by 2025, 19.3 million malignancy cases are relied upon to be analyzed each year and thus it requests for the expansion in early identification of growth. In this manner, as on account of tumor immunology or immuno-oncology, the higher occurrence of molecular resistant biomarkers is in the immense range to reach $45.55 billion 2022 at a CAGR of 11.6% out of 2020.

 

A Compound Annual Growth Research (CAGR) examines of the clinical immunology prescription and immunology showcase has given an aftereffect of 3.63%, from $57.7 billion to $74.1 billion of every 2022. The immunology treatment alongside immunization is foreseen to give a higher blockbuster status of the medications in the market in which the key job is played by the ventures amid the gauge time frame. These have been expected with the status of immunological issue that is pipelined to be extensive, different and contains 2000+ items which get trialed over and over by the key item signs. Henceforth, this item s will add to the worldwide immunology showcase fundamentally.

As a fulfillment, the immunology and immunogenetics advertise drives a higher pervasiveness that repositions awesome open doors for the immunologists, specialists, drug specialists, associations and social orders for immunology and immunogenetics for every one of the classes of living creatures including teachers and understudies from the scholarly community over the globe to give a worldwide gathering to dispersal of enormous research work its outcomes, new thoughts and functional advancement encounters.

 

To Collaborate Scientific Professionals around the World

Conference Date November 2-3, 2020

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Past Conference Report

Supported By

Journal of Clinical & Cellular Immunology Journal of Immunobiology Journal of Immunological Techniques & Infectious Diseases

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by